Rethinking Neurodegenerative Disease Treatment: Target Multiple Pathological Proteins, Not Just One
Perelman School of Medicine at the University of PennsylvaniaNearly all major neurodegenerative diseases are defined by the presence of one of four proteins that have gone rogue. As such, investigational drugs aimed at preventing or slowing the disease often hone in on just one of these proteins. However, targeting multiple proteins at once may be the real key, according to a recent Penn Medicine study.